AbbVie’s red-hot Rinvoq scores fourth FDA approval in five months kdunleavy Fri, 04/29/2022 – 16:40 More: AbbVie's red-hot Rinvoq scores fourth FDA approval in five months Source: fierce
read morePfizer loses top vaccine scientist Jansen who led drive for COVID-19 shot, searches for successor esagonowsky Fri, 04/29/2022 – 15:23 More: Pfizer loses top vaccine scientist Jansen who led drive for COVID-19 shot, searches for successor Source: fierce
read moreNovo’s Wegovy supply rebound on track for later this year as demand stays strong fkansteiner Fri, 04/29/2022 – 13:32 More: Novo's Wegovy supply rebound on track for later this year as demand stays strong Source: fierce
read moreAmid legal tumult, J&J shareholders reject proposal to end talc sales worldwide kdunleavy Fri, 04/29/2022 – 13:04 More: Amid legal tumult, J&J shareholders reject proposal to end talc sales worldwide Source: fierce
read moreAmid Humira’s decline, AbbVie’s Rinvoq falls short of analyst forecasts and Skyrizi delivers zbecker Fri, 04/29/2022 – 11:05 More: Amid Humira's decline, AbbVie's Rinvoq falls short of analyst forecasts and Skyrizi delivers Source: fierce
read moreInRange is the first worldwide multicentre RCT to compare second generation basal insulins More: Insulin glargine meets primary endpoint in Sanofi’s type 1 diabetes study Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals